Skip to main navigation PATIENT PHARMA DIAGNOSTICS COVID-19 SCIENCE CLINICAL STUDIES COMPANY INVESTORS Investor Events Home Investors Investor Events Investor Events Upcoming Events More events are coming soon. Past Events Nov 24, 2021 at 8:00 AM EST 2021 Q3 Earnings Conference Call Nov 8 - Nov 11, 2021 30th Annual Credit Suisse Healthcare Conference Sep 14, 2021 Baird Global Healthcare Conference Sep 7, 2021 at 2:00 PM CEST 2021 Q2 Earnings Conference Call Jun 24, 2021 at 3:00 PM CEST Annual General Meeting of Centogene N.V. Jun 22, 2021 Virtual Investor Event May 12, 2021 Kempen Life Sciences Conference Apr 15, 2021 at 2:00 PM CEST 2020 FY Earnings Conference Call Dec 18, 2020 at 3:00 PM CET Extraordinary General Meeting of Centogene N.V. Dec 16, 2020 at 2:00 PM CET 2020 Q3 Earnings Conference Call Sep 23, 2020 at 2:00 PM CEST 2020 H1 Earnings Conference Call Jun 26, 2020 at 3:00 PM CEST Annual General Meeting of Centogene N.V. Jun 15, 2020 2020 Q1 Earnings Conference Call Apr 23, 2020 2019 FY Earnings Conference Call Dec 5, 2019 2019 Q3 Earnings Conference Call Toolkit Print Page Email Alerts Contact IR Pharma Diagnostics Company Newsletter SUBSCRIBE NOW Follow Us © 2021 CENTOGENE N.V. Imprint Data Protection HIPAA Privacy Terms of Use Terms and Conditions Whistleblower Hotline

Skip to main navigation PATIENT PHARMA DIAGNOSTICS COVID-19 SCIENCE CLINICAL STUDIES COMPANY INVESTORS Corporate Governance Corporate Governance Executive Board Supervisory Board Home Investors Corporate Governance Corporate Governance Centogene is committed to maintaining corporate governance best practices and high ethical standards in its business operations. It is the duty of Centogene’s Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfil its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. Governance Committees Audit Committee Compensation Committee Nomination & Corporate Governance Committee Hubert Birner, PhD Compensation Committee Nomination & Corporate Governance Committee Peer M. Schatz Audit Committee Nomination & Corporate Governance Committee Berndt Modig Audit Committee Guido Prehn Compensation Committee Nomination & Corporate Governance Committee Jonathan G. Sheldon PhD Audit Committee Eric Souêtre, MD Compensation Committee Nomination & Corporate Governance Committee = Chairperson = Member Governance Documents Corporate Governance Statement 2019 123.53 KB Shareholder Dialogue Policy 32.75 KB Supervisory Board Profile 36.45 KB Audit Committee Charter 48.14 KB Corporate Governance Guidelines - Supervisory Board 123.86 KB Compensation Committee Charter 38.98 KB Nomination and Corporate Governance Commitee Charter 37.18 KB Corporate Governance Guidelines - Management Board 126.17 KB Code of Business Conduct and Ethics 80.48 KB Toolkit Print Page Email Alerts Contact IR Pharma Diagnostics Company Newsletter SUBSCRIBE NOW Follow Us © 2021 CENTOGENE N.V. Imprint Data Protection HIPAA Privacy Terms of Use Terms and Conditions Whistleblower Hotline